BRAF and cutaneous melanoma: As previously, BRAF PTEN or BRAF P53 mice, bearing a minimum of one cutaneous melanoma (diameter >7 mm), were continuously treated to a defined endpoint (tumor size ≥15 mm, or ulceration).